Electrophysiology of the neuromuscular junction of the laminin-2 (merosin) deficient C57 BL/6J dy(2J)/dy(2J) dystrophic mouse

Brain Research

Volumn 788, Issue 1-2, 1998, Pages 262-268

  Edwards, Jonathan P ^a   Hatton, Paul A ^a   Wareham, Anthony C ^a  

^a Sch Biol S   (United Kingdom)

Author keywords

dy(2J) dy(2J); Laminin 2; Muscular dystrophy; Neuromuscular junction; Neuromuscular transmission

Indexed keywords

CONOTOXIN; MEROSIN; SODIUM CHANNEL; TETRODOTOXIN; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; ELECTROPHYSIOLOGY; ENDPLATE POTENTIAL; EXTENSOR DIGITORUM LONGUS MUSCLE; MOUSE; MUSCULAR DYSTROPHY; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SOLEUS MUSCLE;

ANIMALS; CELL DIFFERENTIATION; LAMININ; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MOTOR ENDPLATE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER AGENTS;

EID: 0032579841     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00010-9     Document Type: Article

References (38)

1. 2J) mouse. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 112:1995;397-403.
2. Balice-Gordon R.J., Breedlove S.M., Bernstein S., Lichtman J.W. Neuromuscular junctions shrink and expand as muscle fiber size is manipulated: in vivo observations in the androgen-sensitive bulbocavernosus muscle of mice. J. Neurosci. 10:1990;2660-2671.
3. Bradley W.G., Jenkinson M. Neural abnormalities in the dystrophic mouse. J. Neurol. Sci. 25(2):1975;249-255.
4. Bradley W.G., Jaros E., Jenkinson M. The nodes of Ranvier in the nerves of mice with muscular dystrophy. J. Neuropathol. Exp. Neurol. 36(5):1977;797-806.
5. 2J mice. Exp. Neurol. 57:1977;661-681.
6. Carbonetto S., Lindenbaum M. The basement membrane at the neuromuscular junction: a synaptic mediatrix. Curr. Opin. Neurobiol. 5:1995;596-605.
7. 2J ) and normal muscle. Exp. Neurol. 56:1977;480-497.
8. Edwards J.P., Lee C.-C., Duchen L.W. The evolution of an experimental distal motor axonopathy, physiological studies of changes in neuromuscular transmission caused by cycloleucine, an inhibitor of methionine adenosyltransferase. Brain. 117:1994;959-974.
9. 2J). J. Neuropathol. Exp. Neurol. 32(3):1973;345-362.
10. Gonoi T., Ohizumi Y., Nakamura H., Kobayashi J., Catterall W.A. The Conus toxin geographutoxin II distinguishes two functional sodium channel subtypes in rat muscle cells developing in vitro. J. Neurosci. 7(6):1987;1728-1731.
11. Harris J.B. The resting membrane potential of fibres of fast and slow twitch muscles in normal and dystrophic mice. J. Neurol. Sci. 12:1971;45-52.
12. 2J). Exp. Neurol. 48:1975;569-585.
13. Harris J.B., Ribchester R.R. Muscular dystrophy in the mouse: neuromuscular transmission and the concept of functional denervation. Ann. New York Acad. Sci. 317:1979;152-170.
14. Hayashi Y.K., Engvall E., Arikawa-Hiraswa E., Goto K., Koga R., Nonaka I., Sugita H., Arahata K. Abnormal localization of laminin subunits in muscular dystrophies. J. Neurol. Sci. 119:1993;53-64.
15. Hong S.J., Chang C.C. Use of geographutoxin II (μ-conotoxin) for the study of neuromuscular transmission in mouse. Br. J. Pharmacol. 97:1989;934-940.
16. Katz B., Thesleff S. On factors which determine the amplitude of the 'miniature endplate potentials'. J. Physiol. (London). 137:1957;267-278.
17. Kriebel M.E., Hanna R., Muniak C. Synaptic vesicle diameters and synaptic cleft widths at the mouse diaphragm in neonates and adults. Dev. Brain Res. 27:1986;19-29.
18. Kuno M., Turkanis S.A., Weakley J.N. Correlation between nerve terminal size and transmitter release at the neuromuscular junction of the frog. J. Physiol. (London). 213:1971;545-556.
19. Leiro I., Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblasts, is expressed late in nerve and muscle development. Proc. Natl. Acad. Sci. U.S.A. 85:1988;1544-1548.
20. Lupa M.T., Krzemien D.M., Schaller K.L., Caldwell J.H. Aggregation of sodium channels during development of the neuromuscular junction. J. Neurosci. 13(3):1993;1326-1336.
21. Lyons P.R., Slater C.R. Structure and function of the neuromuscular junction in young adult mdx mice. J. Neurocytol. 20:1991;969-981.
22. Martin A.R. A further study of the statistical composition of the end-plate potential. J. Physiol. (London). 130:1955;114-122.
23. Martin A.R. Quantal nature of synaptic transmission. Physiol. Rev. 46:1966;51-66.
24. McLachlan E.M., Martin A.R. Non-linear summation of end-plate potentials in the frog and mouse. J. Physiol. (London). 311:1981;307-324.
25. McIsaac G., Kiernan J.A. Complete staining of neuromuscular innervation with bromoindigo and silver. Stain. Technol. 49(4):1974;211-214.
26. Meier H., Southard J.L. Muscular dystrophy in the mouse caused by an allele at the dy-locus. Life Sci. 9:1970;137-144.
27. Michelson A.M., Russell E.S., Harman P.J. Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc. Natl. Acad. Sci. U.S.A. 41:1955;1079-1084.
28. C.G. Muniak, M.E. Kriebel, C.G. Carlsom, Changes in MEPP and EPP amplitude distributions in the mouse diaphragm during synapse formation and degeneration, Brain Res. (1982) 123-138.
29. Nagel A., Lehmann-Horn F., Engel A.G. Neuromuscular transmission in the mdx mouse. Muscle Nerve. 13:1990;742-749.
30. Noakes P.G., Gautam M., Mudd J., Sanes J.R., Merlie J.P. Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin Beta2. Nature (London). 374:1995;258-262.
31. Ozawa E., Yoshida M., Suzuki A., Mizuno Y., Hagiwara Y., Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum. Mol. Genet. 4:1995;1711-1716.
32. Sewry C.A., Philpot J., Mahony D., Wilson L.A., Muntoni F., Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromuscular Disord. 5(4):1995;307-316.
33. Shalton P.M., Wareham A.C. Some factors affecting spontaneous transmitter release in dystrophic mice. Muscle Nerve. 3:1980;120-127.
34. Stirling C.A. Abnormalities in Schwann cell sheaths in spinal nerve roots of dystrophic mice. J. Anat. 119:1975;169-180.
35. Sunuda Y., Bernier S.M., Kozak C.A., Yamada Y., Cambell K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin m chain gene to dy locus. J. Biol. Chem. 269(19):1994;13729-13732.
36. Tome F.M.S., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B., Bardis A., Campbell K.P., Fardeau M. Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. Ser. III. 317:1994;351-357.
37. Xu H., Christmas P., Wu X.R., Wewer U.M., Engvall E. Defective muscle basement and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. U.S.A. 91(12):1994;5572-5576.
38. Xu H., Wu X.R., Wewer U.M., Engvall E. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat. Genet. 8:1994;297-302.